Showing results (1151-1160 of 1,179) with videos related to

Sort By:
Pageof 118
Neuro-Oncology|April 8, 2022
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)Ami V Desai, Giles W Robinson, Karen Gauvain, et al.
Brain : a Journal of Neurology|June 7, 2023
Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variantsChristopher J Record, Mariola Skorupinska, Matilde Laura, et al.
Frontiers in Immunology|March 17, 2023
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP studyJoanna Waldock, Carol D Weiss, Wei Wang, et al.
JAMA Psychiatry|November 30, 2022
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewBrian D Kiluk, Bethea A Kleykamp, Sandra D Comer, et al.
Science Translational Medicine|April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodiesSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
The Journal of Emergency Medicine|July 17, 2010
The future of emergency medicineSandra M Schneider, Angela F Gardner, Larry D Weiss, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Pain|July 10, 2012
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendationsDennis C Turk, Alec B O'Connor, Robert H Dworkin, et al.
Neuro-Oncology|July 5, 2022
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensusPeter M K de Blank, Andrea M Gross, Srivandana Akshintala, et al.
Scientific Reports|December 29, 2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vectorM Giel-Moloney, M Esteban, B H Oakes, et al.
Pageof 118